Most recurrent ovarian cancer cases arise in patients previously treated with PARP inhibitors making these results noteworthy ...
A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.
Morning Overview on MSN
Human cells self-destruct when viruses mess with RNA
A groundbreaking study reveals that human cells initiate self-destruction processes when viruses disrupt RNA production, ...
Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – ...
If Oktoberfest brings links to your plate, there’s more to know about the meat- and vegetable-based casings they’re stuffed ...
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...
Gilead Sciences, Inc. will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations across HIV, ...
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback